Parameter | Study inclusion (n = 12) | 6 months after study start (n = 10) | P-value* | 12 months after study start (n = 9) | P-value** |
---|---|---|---|---|---|
HR (bpm) | 93 ± 26 | 91 ± 18 | ns | 86 ± 19 | ns |
Systolic BP (mmHg) | 96 ± 18 | 104 ± 12 | ns | 97 ± 16 | ns |
Diastolic BP (mmHg) | 59 ± 12 | 60 ± 5 | ns | 57 ± 15 | ns |
LVESD (mm) | 20 ± 8 | 21 ± 7 | ns | 21 ± 8 | ns |
LVEDD (mm) | 31 ± 9 | 34 ± 8 | ns | 32 ± 9 | ns |
LVESV (ml) | 16 ± 14 | 18 ± 12 | ns | 19 ± 17 | ns |
LVEDV (ml) | 40 ± 28 | 53 ± 28 | 0.028 | 48 ± 33 | 0.011 |
SV (ml) | 25 ± 16 | 32 ± 17 | 0.022 | 30 ± 17 | 0.021 |
EF (%) | 68 ± 14 | 69 ± 14 | ns | 67 ± 10 | ns |
FS (%) | 38 ± 13 | 39 ± 11 | ns | 37 ± 7 | ns |
E/A | 1.3 ± 0.7 | 1.3 ± 0.7 | ns | 1.7 ± 0.6 | 0.018 |
IVRT (ms) | 115 ± 46 | 100 ± 42 | 0.047 | 94 ± 30 | 0.033 |
RVSP (mmHg) | 29 ± 8 | 30 ± 6 | ns | 30 ± 5 | ns |